Poland Switches from Rx-To-OTC Mylan's Duspatalin For IBS, Plus Orion's ED Treatment
Executive Summary
Poland's medicines regulator has approved the switch of Mylan's Duspatalin and Orion's Valinger.
You may also be interested in...
OTCs Under Threat In Europe: Calls To Reverse-Switch Codeine And Others In Poland And Ireland
Poland's ministry of health is calling for codeine, dextromethorphan and pseudoephedrine to be reverse-switched from OTC to prescription status in response to abuse of the drugs by adolescents. At the same time, an academic paper argues Ireland should restrict codeine to prescription-only sale to combat an addiction epidemic "verging on eruption."
Bayer's Canesten Switched From Rx-To-OTC Status In Poland
Poland's drug regulator, URPL, has switched Bayer's Canesten vaginal yeast infection treatment from prescription-to-OTC status. It is the regulator's fourth switch in 2019 alone.
Poland Kick Starts 2019 With Three Rx-To-OTC Switches
Clotrimazole, pyrantel, and ciclopirox olamine have been switched from prescription-to-OTC status by Poland's national drug regulator.